During the past decade, New Phase Research & Development conducted 35 clinical trials. In the 10-year time frame, 35 clinical trials started and 29 clinical trials were completed, i.e. on average, 82.9% percent of trials that started reached the finish line to date. In the past 5 years, 17 clinical trials started and 18 clinical trials were completed. i.e. 105.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "New Phase Research & Development" #1 sponsor was "Eli Lilly and Company" with 6 trials, followed by "Pfizer" with 4 trials sponsored, "Gilead Sciences" with 3 trials sponsored, "Verona Pharma plc" with 3 trials sponsored and "Gan and Lee Pharmaceuticals, USA" with 3 trials sponsored. Other sponsors include 21 different institutions and companies that sponsored additional 29 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "New Phase Research & Development" #1 collaborator was "Iqvia Pty Ltd" with 3 trials as a collaborator, "Allergan Sales, LLC" with 2 trials as a collaborator, "AbCellera Biologics Inc." with 1 trials as a collaborator, "Camurus AB" with 1 trials as a collaborator and "GlaxoSmithKline" with 1 trials as a collaborator. Other collaborators include 1 different institutions and companies that were collaborators in the rest 11 trials.

According to Clinical.Site data, the most researched conditions in "New Phase Research & Development" are "Type 2 Diabetes Mellitus" (7 trials), "Cardiovascular Disease" (3 trials), "Chronic Obstructive Pulmonary Disease" (3 trials), "COPD" (2 trials) and "Covid19" (2 trials). Many other conditions were trialed in "New Phase Research & Development" in a lesser frequency.

Most popular intervention types in "New Phase Research & Development" are "Drug" (39 trials), "Biological" (4 trials), "Behavioral" (3 trials), "Other" (3 trials) and "Combination Product" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (29 trials), "Diet" (3 trials), "Exercise" (3 trials), "Ranolazine" (3 trials) and "Dulaglutide" (2 trials). Other intervention names were less common.

The vast majority of trials in "New Phase Research & Development" are 44 trials for "All" genders.

Currently, there are NaN active trials in "New Phase Research & Development". undefined are not yet recruiting, 3 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 36 completed trials in New Phase Research & Development, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in New Phase Research & Development, 0 "Phase 1" clinical trials were conducted, 15 "Phase 2" clinical trials and 27 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".